COST heads into its September 24 earnings print with the stock down nearly 7% over the past month, a freshly trimmed target from a bellwether firm, and the put/call ratio ticking back up from last week's neutral read.
The analyst angle is the freshest development this week. The Street remains broadly constructive — 20 buys against 13 holds, with no sells — but BofA cut its target to $1,095 from $1,200 on Tuesday while keeping its Buy rating intact. That move is worth noting: at $901, the stock now trades roughly 21% below BofA's revised target, itself down from a level that implied close to 30% upside just two weeks ago. Oppenheimer held its Outperform and its $1,160 target unchanged, signalling some disagreement on the magnitude of the reset. The bull case rests on Costco's membership renewal engine and grocery-anchored traffic. Bears flag California concentration, rising operating costs, and a premium valuation that leaves little cushion: the PE has compressed roughly 6 turns over the past month to 37x, and EV/EBITDA has shed more than 2.5 turns to 23x. Neither is cheap, even after the slide.
Options positioning has drifted slightly more cautious than last week's note described. The PCR edged back to 1.10 Tuesday — almost exactly in line with its 20-day mean of 1.10, a z-score near zero. Two weeks ago the ratio was running around 1.04, the calmest read since the defensive surge through July and August peaked above 1.29. The mild uptick this week does not signal renewed alarm; it looks more like a normalisation after last week's calm, with the September 24 print now eight days away. The 52-week range on the PCR runs from 0.74 to 1.40, so the current level remains well inside its recent boundaries — positioning is neither hedged nor particularly exposed.
Short interest tells a quiet story. At 1.7% of the free float, it is too low to read as a meaningful bearish signal. It has grown about 10% over the past month in share terms, but borrow remains almost entirely frictionless — availability is effectively uncapped, and the cost to borrow at 0.31% is down roughly 18% from a month ago. The short-score reading of 32.7 has barely moved in two weeks. None of this signals any structural shift in how bears are positioned; it reflects a large, liquid stock where shorting is easy and mostly done by hedgers rather than directional bears.
The insider activity this week is compensation mechanics rather than conviction. Five EVPs all received equity grants and simultaneously surrendered shares to cover tax withholding on September 10 — a standard compensation exercise with no signal value on the stock's direction. The 90-day net insider position is a negligible net negative, consistent with a company where compensation-related activity dominates the Form 4 flow.
The prior note flagged a 13% dividend increase as a supporting data point. The dividend history in the dataset runs only to 2022, so that increase cannot be verified here, but no subsequent data contradicts it either. If confirmed, it reinforces the factor scores: EPS momentum ranks in the 92nd percentile on a 30-day basis, and the dividend score ranks 86th. The analyst-recommendation differential score is even more striking at the 99th percentile — the gap between current ratings and historical consensus is the widest in the universe. What to watch on September 24 is whether comparable-sales trends and membership renewal rates justify the multiple that even the most cautious bulls are still applying.
See the live data behind this article on ORTEX.
Open COST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
